Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Strategically Disrupting Drug Delivery
Expanding the applicability of edible delivery technology within the drug industry Creating strategic partnerships through licensing agreements Breakthrough in nicotine absorption study supports further investigation into the many possible uses beyond the cannabis and nicotine industries Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a drug delivery platform innovator, partners with leading companies within the drug industry. The company is known primarily for removing objectionable flavors while improving the effectiveness of gastro-intestinal delivery of edible cannabinoid consumer products, but the company is now working to expand the applicability of its technology beyond the cannabis industry. DehydraTECH™ is Lexaria’s edible delivery technology…